Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls

Psychoneuroendocrinology

Volumn 31, Issue 1, 2006, Pages 100-107

  Held, Katja ^a   Antonijevic, Irina ^a   Murck, Harald ^a   Kuenzel, Heike ^a   Steiger, Axel ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

ACTH; Cortisol; Depression; NPY; Prolactin; Sleep

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE; CORTICOTROPIN; HYDROCORTISONE; NEUROHORMONE; NEUROPEPTIDE Y;

ADAPTATION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; DRUG EFFECT; ELECTROENCEPHALOGRAM; ENDOCRINE FUNCTION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; MEASUREMENT; NIGHT; PATIENT; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SLEEP; WAKEFULNESS;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEUROPEPTIDE Y; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SLEEP;

EID: 27944454011     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2005.05.015     Document Type: Article

References (34)

1. I.A. Antonijevic, H. Murck, S. Bohlhalter, R.M. Frieboes, F. Holsboer, and A. Steiger NPY promotes sleep and inhibits ACTH and cortisol release in young men Neuropharmacology 39 2000 1474 1481
2. I.A. Antonijevic, H. Murck, R.M. Frieboes, and A. Steiger Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls - part II: hormone secretion Sleep Res. Online 3 2000 15 21
3. C.C. Chao, K.A. Scribner, J.E. Dixon, and P.V. Malven Failure of neuropeptide Y to modulate the release of LH and prolactin by cultured bovine pituitary cells Domest. Anim. Endocrinol. 4 1987 309 314
4. C.L. Ehlers, C. Somes, A. Lopez, D. Kirby, and J.E. Rivier Electrophysiological actions of neuropeptide Y and its analogs: new measures for anxiolytic therapy? Neuropsychopharmacology 17 1997 34 43
5. C.L. Ehlers, C. Somes, E. Seifritz, and J.E. Rivier CRF/NPY interactions: a potential role in sleep dysregulation in depression and anxiety Depress. Anxiety 6 1997 1 9
6. B.W. Ellis, M.W. Johns, R. Lancaster, P. Raptopoulos, N. Angelopoulos, and R.G. Priest The St Mary's Hospital sleep questionnaire: a study of reliability Sleep 4 1981 93 97
7. R.M. Frieboes, H. Murck, G.K. Stalla, I.A. Antonijevic, and A. Steiger Enhanced slow wave sleep in patients with prolactinoma J. Clin. Endocrinol. Metab. 83 1998 2706 2710
8. J. Guldner, T. Schier, E. Friess, M. Colla, F. Holsboer, and A. Steiger Reduced efficacy of growth hormone-releasing hormone in modulating sleep endocrine activity in the elderly Neurobiol. Aging 18 1997 491 495
9. M. Hamilton Development of a rating scale for primary depressive illness Br. J. Soc. Clin. Psychol. 6 1967 278 296
10. A. Harfstrand, P. Eneroth, L. Agnati, and K. Fuxe Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines Regul. Pept. 17 1987 167 179
11. M. Heilig The NPY system in stress, anxiety and depression Neuropeptides 38 2004 213 224
12. M. Heilig, and E. Widerlov Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses Acta Psychiatr. Scand. 82 1990 95 114
13. M. Heilig, S. McLeod, M. Brot, S.C. Heinrichs, F. Menzaghi, and G.F. Koob Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects Neuropsychopharmacology 8 1993 357 363
14. M. Heilig, O. Zachrisson, A. Thorsell, A. Ehnvall, S. Mottagui-Tabar, M. Sjogren, M. Asberg, R. Ekman, C. Wahlestedt, and H. Agren Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism J. Psychiatr. Res. 38 2004 113 121
15. K. Held, H. Künzel, M. Ising, D.A. Schmid, A. Zobel, H. Murck, F. Holsboer, and A. Steiger Treatment with the CRH-1-receptor antagonist R121919 improves sleep EEG in patients with depression J. Psychiatr. Res. 38 2004 129 136
16. F. Holsboer Neuroendocrinology of affective disorders F.E. Bloom D.J. Kupfer Neuropsychopharmacology. 4th Generation of Progress 1995 Raven Press New York 957 970
17. F. Holsboer The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety J. Psychiatr. Res. 33 1999 181 214
18. H. Husum, J.D. Mikkelsen, S. Hogg, A.A. Mathe, and A. Mork Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram Neuropharmacology 39 2000 1463 1473
19. P.A. Jimenez-Vasquez, D.H. Overstreet, and A.A. Mathe Neuropeptide Y in male and female brains of Flinders Sensetive Line, a rat model of depression. Effects of elctroconvulsive stimuli J. Psychiatr. Res. 34 2000 405 412
20. L. Kerkerian, J. Guy, G. Lefevre, and G. Pelletier Effects of neuropeptide Y (NPY) on the release of anterior pituitary hormones in the rat Peptides 6 1985 1201 1204
21. D.J. Kupfer, C.F.3. Reynolds, R.F. Ulrich, D.H. Shaw, and P.A. Coble EEG sleep, depression, and aging Neurobiol. Aging 3 1982 351 360
22. P. Linkowski, J. Mendlewicz, M. Kerkhofs, R. Leclercq, J. Golstein, M. Brasseur, G. Copinschi, and E. Van Cauter 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment J. Clin. Endocrinol. Metab. 65 1987 141 152
23. C.B. Nemeroff The role of corticotropin-releasing factor in the pathogenesis of major depression Pharmacopsychiatry 21 1988 76 82
24. F. Obál Jr., B. Kacsóh, S. Bredow, N. Guha-Thakurta, and J.M. Krueger Sleep in rats rendered chronically hyperprolactinemic with anterior pituitary grafts Brain Res. 755 1997 130 136
25. M.J. Owens, and C.B. Nemeroff The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies Ciba Found. Symp. 172 1993 296 308
26. M.J. Owens, G. Bissette, and C.B. Nemeroff Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain Synapse 4 1989 196 202
27. A. Rechtschaffen, and A. Kales A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects 1968 US Department of Health, Education & Welfare, Neurological Information Network Bethesda, MD
28. V. Rettori, L. Milenkovic, M. Riedel, and S.M. McCann The role of neuropeptide Y (NPY) in control of gonadotropin and prolactin release in the rat Gynecol. Endocrinol. 4 1990 169 179
29. T.J. Sajdyk, M.G. Vandergriff, and D.R. Gehlert Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test Eur. J. Pharmacol. 368 1999 143 147
30. A. Steiger Sleep and the hypothalamo-pituitary-adrenocortical system Sleep Med. Rev. 6 2002 125 138
31. A. Steiger, and F. Holsboer Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission Psychiatry Res. 72 1997 81 88
32. A. Van Coevorden, J. Mockel, E. Laurent, M. Kerkhofs, M. L'Hermite-Balériaux, C. Decoster, P. Neve, and E. Van Cauter Neuroendocrine rhythms and sleep in aging men Am. J. Physiol. 260 1991 E651 E661
33. E. Widerlov, L.H. Lindstrom, C. Wahlestedt, and R. Ekman Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively J. Psychiatr. Res. 22 1988 69 79
34. S.Q. Zhang, M. Kimura, and S. Inoue Effects of prolactin on sleep in cyclic rats Psychiatry Clin. Neurosci. 53 1999 101 103